Humoral and cellular immune responses following BNT162b2 XBB.1.5 vaccination.

Authors :: Stankov MV
Hoffmann M
Gutierrez Jauregui R
Cossmann A
Morillas Ramos G
Graalmann T
Winter EJ
Friedrichsen M
Ravens I
Ilievska T
Ristenpart J
Schimrock A
Willenzon S
Ahrenstorf G
Witte T
Förster R
Kempf A
Pöhlmann S
Hammerschmidt SI
Dopfer-Jablonka A
Behrens GMN
Source :: The Lancet. Infectious diseases [Lancet Infect Dis] 2024 Jan; Vol. 24 (1), pp. e1-e3. Date of Electronic Publication: 2023 Nov 20.
Publication Year :: 2024
Abstract: Competing Interests: MH, AK, and SP did the contract research (testing of vaccinee sera for neutralising activity against SARS-CoV-2) for Valneva, unrelated to this work. GMNB served as an adviser for Moderna, unrelated to this work. SP served as an adviser for BioNTech, unrelated to this work. AD-J and TW served as an adviser for Pfizer, unrelated to this work. All other authors declare no competing interests. MVS, MH, and RGJ are co-first authors. AD-J and GMNB are co-senior authors.